These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10900293)

  • 1. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.
    Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M
    Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
    Fujiwara Y; Tagami S; Kawakami Y
    J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
    Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
    Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.
    Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    Nephrol Dial Transplant; 2001 Mar; 16(3):529-36. PubMed ID: 11239027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
    Fioretto P; Stehouwer CD; Mauer M; Chiesura-Corona M; Brocco E; Carraro A; Bortoloso E; van Hinsbergh VW; Crepaldi G; Nosadini R
    Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy.
    Rinno H; Kuramoto T; Iijima T; Yagame M; Tomino Y
    J Clin Lab Anal; 1996; 10(3):119-24. PubMed ID: 8731497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
    Okumura K; Aso Y
    Metabolism; 2003 Nov; 52(11):1517-22. PubMed ID: 14624417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Takemura Y
    Diabetes Res Clin Pract; 1996 Jul; 33(2):99-104. PubMed ID: 8879964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury.
    Aso Y; Inukai T; Takemura Y
    Metabolism; 1998 Mar; 47(3):362-5. PubMed ID: 9500578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients.
    Morise T; Takeuchi Y; Kawano M; Koni I; Takeda R
    Diabetes Care; 1995 Jan; 18(1):87-9. PubMed ID: 7698054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial Markers: Thrombomodulin and Von Willebrand Factor and Risk of Kidney Thrombosis After Transplantation.
    Ziętek Z
    Transplant Proc; 2021 Jun; 53(5):1562-1569. PubMed ID: 33892933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
    Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
    Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein abnormalities in diabetic nephropathy.
    Hirano T
    Kidney Int Suppl; 1999 Jul; 71():S22-4. PubMed ID: 10412730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever.
    George F; Brouqui P; Boffa MC; Mutin M; Drancourt M; Brisson C; Raoult D; Sampol J
    Blood; 1993 Oct; 82(7):2109-16. PubMed ID: 7691249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.